MOLECULARHEALTH Trademark

Trademark Overview


On Thursday, March 29, 2012, a trademark application was filed for MOLECULARHEALTH with the United States Patent and Trademark Office. The USPTO has given the MOLECULARHEALTH trademark a serial number of 85583345. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by Molecular Health AG. The MOLECULARHEALTH trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer

Data collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providi...

Providing an online database featuring medical, pharmaceutical and genomic information for medical diagnostic or treatment purposes; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; medical consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others
molecularhealth

General Information


Serial Number85583345
Word MarkMOLECULARHEALTH
Filing DateThursday, March 29, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number4710227
Registration DateTuesday, March 31, 2015
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 1, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"MOLECULAR HEALTH"
Description of MarkThe mark consists of circle within a circle and an arrow within the inner circle and the word "MOLECULARHEALTH" to the right of the image.
Goods and ServicesData collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
Goods and ServicesData collection for medical and scientific research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for medical and scientific research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
Goods and ServicesProviding an online database featuring medical, pharmaceutical and genomic information for medical diagnostic or treatment purposes; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; medical consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others
Pseudo MarkMOLECULAR HEALTH

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMolecular Health GMBH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHeidelberg 69115
DD

Party NameMolecular Health GMBH
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressHeidelberg 69115
DD

Party NameMolecular Health AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address4010 Basel
CH

Party NameMolecular Health AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address4010 Basel
CH

Trademark Events


Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, March 31, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 31, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, February 26, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, February 26, 2015NOTICE OF ALLOWANCE CANCELLED
Tuesday, February 24, 2015TEAS DELETE 1(B) BASIS RECEIVED
Thursday, August 28, 2014NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 26, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 20, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 2, 2014NOTICE OF PUBLICATION
Tuesday, July 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, June 11, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 23, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 15, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, May 15, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 15, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, May 15, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, April 24, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, April 24, 2014PRIORITY ACTION E-MAILED
Thursday, April 24, 2014PRIORITY ACTION WRITTEN
Thursday, March 20, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 14, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 25, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 25, 2013INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 25, 2013SUSPENSION INQUIRY WRITTEN
Thursday, September 19, 2013SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, March 14, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 14, 2013LETTER OF SUSPENSION E-MAILED
Thursday, March 14, 2013SUSPENSION LETTER WRITTEN
Thursday, March 7, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, March 7, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, January 31, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 31, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 24, 2013ASSIGNED TO LIE
Tuesday, January 22, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 22, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, July 22, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, July 22, 2012NON-FINAL ACTION E-MAILED
Sunday, July 22, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 10, 2012ASSIGNED TO EXAMINER
Thursday, April 5, 2012NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, April 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 2, 2012NEW APPLICATION ENTERED IN TRAM